相似文献
1
Dose of proton pump inhibitors and the CYP2C19 genotype.
Basic Clin Pharmacol Toxicol. 2004 Jul;95(1):1. doi: 10.1111/j.1742-7843.2004.pto950101.x.
2
[Dosaging of proton pumps inhibitors].
Tidsskr Nor Laegeforen. 2006 Sep 21;126(18):2397-9.
3
[Dosaging of proton pumps inhibitors].
Tidsskr Nor Laegeforen. 2006 Nov 16;126(22):2985; author reply 2985.
4
[Cytochrome P450 2C19 genotype -based second line therapy with amoxicillin and lansoprazole after failure of initial helicobacter pylori eradication therapy].
Nihon Rinsho. 2005 Dec;63 Suppl 12:450-3.
5
The efficacy of Helicobacter pylori eradication related to CYP2C19 metabolism.
Aliment Pharmacol Ther. 2005 Aug 1;22(3):274-5; author reply 275-6. doi: 10.1111/j.1365-2036.2005.02545.x.
6
Pharmacogenomics of proton pump inhibitors.
Pharmacogenomics. 2004 Mar;5(2):181-202. doi: 10.1517/phgs.5.2.181.27483.
7
[Recent topics on important drugs for H. pylori eradication: Omeprazole].
Nihon Rinsho. 2005 Nov;63 Suppl 11:333-7.
8
[Recent topics on important drugs for H. pylori eradication: Rabeprazole].
Nihon Rinsho. 2005 Nov;63 Suppl 11:350-3.
9
[Influence of cytochrome P450 2C19 genetic polymorphism on H. pylori eradication therapy].
Nihon Rinsho. 2005 Nov;63 Suppl 11:569-72.
Zotero 插件